Cargando…
601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506497/ http://dx.doi.org/10.1016/j.annonc.2020.08.715 |
| _version_ | 1783585031094009856 |
|---|---|
| author | Gelderblom, H. Gietema, J.A. Desar, I.M.E. Ajmone, N.M. Jalving, M. Kroep, J.R. Nicolas, V. Vaslin, A. Tobal, K. Purcea, D. van Haren, S.F. Damstrup, L. |
| author_facet | Gelderblom, H. Gietema, J.A. Desar, I.M.E. Ajmone, N.M. Jalving, M. Kroep, J.R. Nicolas, V. Vaslin, A. Tobal, K. Purcea, D. van Haren, S.F. Damstrup, L. |
| author_sort | Gelderblom, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506497 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064972020-09-23 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours Gelderblom, H. Gietema, J.A. Desar, I.M.E. Ajmone, N.M. Jalving, M. Kroep, J.R. Nicolas, V. Vaslin, A. Tobal, K. Purcea, D. van Haren, S.F. Damstrup, L. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506497/ http://dx.doi.org/10.1016/j.annonc.2020.08.715 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gelderblom, H. Gietema, J.A. Desar, I.M.E. Ajmone, N.M. Jalving, M. Kroep, J.R. Nicolas, V. Vaslin, A. Tobal, K. Purcea, D. van Haren, S.F. Damstrup, L. 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title | 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title_full | 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title_fullStr | 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title_full_unstemmed | 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title_short | 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| title_sort | 601tip first-in-human phase i study of a novel oral wee1 inhibitor (debio 0123) in combination with carboplatin in patients with advanced solid tumours |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506497/ http://dx.doi.org/10.1016/j.annonc.2020.08.715 |
| work_keys_str_mv | AT gelderblomh 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT gietemaja 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT desarime 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT ajmonenm 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT jalvingm 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT kroepjr 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT nicolasv 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT vaslina 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT tobalk 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT purcead 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT vanharensf 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours AT damstrupl 601tipfirstinhumanphaseistudyofanoveloralwee1inhibitordebio0123incombinationwithcarboplatininpatientswithadvancedsolidtumours |